FOXP3 and primary biliary cholangitis: As shown in Table 2 and Figure 1, patients with CHB and CHC as well as those with the other hepatic diseases (NAFLD, autoimmune hepatitis, PBC, and MTX-related hepatotoxicity) presented a statistically significant increase of Foxp3 mRNA levels compared to normal controls.